| Literature DB >> 26577106 |
J A Virizuela1, J Carratalà2, J M Aguado3, D Vicente4, M Salavert5, M Ruiz6, I Ruiz7, F Marco8, M Lizasoain3, P Jiménez-Fonseca9, C Gudiol2,10, J Cassinello11, A Carmona-Bayonas12, M Aguilar13, J J Cruz14.
Abstract
An expert group from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC, for its acronym in Spanish) and the Spanish Society of Medical Oncology (SEOM, for its acronym in Spanish) have reviewed the main aspects to be considered when evaluating patients with solid cancer and infectious complications contained in this article. Recommendations have, therefore, been put forth regarding the prophylaxis of the most prevalent infections in these patients, the use of vaccines, measures to control infection through vascular catheters, and preventing infection in light of certain surgical maneuvers. The following is a revision of the criteria for febrile neutropenia management and the use of colony-stimulating factors and closes with several guidelines for treating the cancer patient with serious infection. The document concludes with a series of measures to control hospital infection.Entities:
Keywords: Cancer; Febrile neutropenia; Infection; Prophylaxis; Risk factors
Mesh：
Year: 2015 PMID： 26577106 DOI： 10.1007/s12094-015-1442-4
Source DB: PubMed Journal: Clin Transl Oncol ISSN： 1699-048X Impact factor: 3.340